NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Testing the Efficacy of Safe South Africa
Testing the Efficacy of Safe South Africa

NCT06750107

CompletedPhase 3

Sponsor: Brown University

Conditions: Intervention, Control

Interventions: Safe South Africa

Countries: South Africa

In this study, investigators will examine the efficacy of Safe South Africa, a behavioral intervention that is developmentally- and gender-tailored to prevent human immunodeficiency virus (HIV) and intimate partner violence (IPV) among adolescent boys. South Africa faces some of the highest global rates of HIV and IPV with sustained high incidence of HIV and alarming rates of IPV among adolescents and thus, is an ideal site to advance prevention science to tackle these urgent public health priorities. Testing the efficacy of an integrated intervention to prevent HIV risk behavior and IPV for adolescent boys can support optimal health for young people, their future partners, and society.

Eligibility overview

Sex: MALE

Age: 15 Years to 17 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* identification as boys
* ages 15-17 years
* enrolled at public high schools in South Africa situated in communities with high rates of HIV and violence

Exclusion Criteria:

* does not have written parental consent
* does not have written assent
Locations (1)
  • Cape Town, South Africa